NEW YORK — Kansas City Royals pitcher Eric Skoglund was suspended Wednesday for the season’s first 80 video games after testing optimistic for 2 performance-enhancing substances.
The MLB commissioner’s workplace stated the optimistic assessments have been for selective androgen receptor modulators S-22 (Ostarine) and LGD-4033 (Ligandrol).
Royals basic supervisor Dayton Moore stated in a press release Skoglund “unknowingly made a mistake” and “we stay pleased with who Eric is as an individual and can help him as a corporation.”
Skoglund was 1-6 with a 5.14 ERA final season. The 26-year-old lefty was within the rotation in April and Could, missed the subsequent three months due to an elbow sprain and pitched properly in September.
The 6-foot-7 Skoglund made his huge league debut in 2017, going 1-2 with a 9.50 ERA in seven video games. He was a candidate to start this season within the rotation, a yr after the Royals went 58-104 and completed final within the AL Central.
Skoglund is the primary participant to be suspended this yr underneath the key league drug program. Ten gamers have been suspended underneath this system final yr, together with Robinson Cano, Jorge Polanco and Welington Castillo.
“Sadly, when one thing like this happens, I instantly take into consideration how a lot work and dedication our medical employees does speaking to the gamers in regards to the significance of being cautious about what they put of their our bodies,” Moore stated.
“Eric is an amazing younger man, and he unknowingly made a mistake, and he can have to settle for his suspension, work laborious and be prepared to go after the suspension is served,” Moore stated.